Pharmapedia Pro
Medicines/Generics/Lamivudine

Lamivudine

Generic medicine reference

Not yet clinically reviewed

This entry was migrated from the earlier Pharmapedia app bundle and has not been reviewed by a named clinician on this site. It is provided for educational reference only — verify dosage and safety information against current, authoritative sources and a qualified healthcare professional before any clinical use.

Spot an error in this entry? Submit a correction
Overview
Lamivudine is an antiviral medicine that prevents human immunodeficiency virus (HIV) or hepatitis B virus from multiplying in your body. Epivir is for treating HIV in adults and children at least 3 months old. HIV is the virus that can cause acquired immunodeficiency syndrome (AIDS). Epivir is not a cure for HIV or AIDS. Epivir-HBV is for treating hepatitis B in adults and children at least 2 years old. Epivir-HBV should not be used in people who are infected with both hepatitis B and HIV. Lamivudine may also be used for purposes not listed in this medication guide.
Indications
Lamivudine is an antiviral medicine that prevents human immunodeficiency virus (HIV) or hepatitis B virus from multiplying in your body. Epivir is for treating HIV in adults and children at least 3 months old. HIV is the virus that can cause acquired immunodeficiency syndrome (AIDS). Epivir is not a cure for HIV or AIDS. Epivir-HBV is for treating hepatitis B in adults and children at least 2 years old. Epivir-HBV should not be used in people who are infected with both hepatitis B and HIV. Lamivudine may also be used for purposes not listed in this medication guide.
Contraindications
You should not take lamivudine if you are allergic to it. You should not take Epivir-HBV (for treating hepatitis B) if you also take other medicine that contains lamivudine or emtricitabine, which includes Atripla, Biktarvy , Cimduo, Combivir , Complera, Descovy, Emtriva, Epzicom, Genvoya, Odefsey, Stribild, Symfi, Triumeq, Trizivir, and Truvada. Tell your doctor if you have ever had: liver disease (especially hepatitis B or C, or a liver transplant ); pancreatitis ; kidney disease; or diabetes ( liquid lamivudine contains 3 to 4 grams of sucrose per dose). You may develop lactic acidosis, a dangerous build-up of lactic acid in your blood. This may be more likely if you have other medical conditions, if you've taken HIV medication for a long time, or if you are a woman. Ask your doctor about your risk. Tell your doctor if you are pregnant, and use your medications properly to control your infection . HIV can be passed to your baby if the virus is not controlled during pregnancy. Your name may be listed on a registry to track any effects of antiviral medicine on the baby. You should not breastfeed while you are using lamivudine to treat hepatitis B. Women with HIV or AIDS should not breast feed a baby. Even if your baby is born without HIV, the virus may be passed to the baby in your breast milk.
Side Effects
Get emergency medical help if you have signs of an allergic reaction : hives; difficult breathing; swelling of your face, lips, tongue, or throat. Mild symptoms of lactic acidosis may worsen over time , and this condition can be fatal. Get emergency medical help if you have: unusual muscle pain , trouble breathing, stomach pain, vomiting, irregular heart rate, dizziness, feeling cold, or feeling very weak or tired. Lamivudine may cause serious side effects. Call your doctor at once if you have: pancreas problems --severe pain in your upper stomach spreading to your back, nausea and vomiting, fast heart rate ; or liver problems --swelling around your midsection, right-sided upper stomach pain, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes). Lamivudine affects your immune system, which may cause certain side effects (even weeks or months after you've taken lamivudine). Tell your doctor if you have: signs of a new infection --fever, night sweats, swollen glands, cold sores , cough, wheezing, diarrhea, weight loss ; trouble speaking or swallowing, problems with balance or eye movement, weakness or prickly feeling; or swelling in your neck or throat (enlarged thyroid), menstrual changes, impotence . Common side effects of lamivudine may include: nausea, diarrhea; headache; fever, tiredness, general ill feeling; ear infection --ear pain or full feeling, trouble hearing, drainage from the ear, fussiness in a child; or nose or throat infection --stuffy nose, sneezing, sore throat , cough. This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Warnings
You should not take Epivir-HBV (for treating hepatitis B) if you also take other medicine that contains lamivudine or emtricitabine . Lamivudine can cause severe or life-threatening effects on your liver or pancreas. Call your doctor at once if you have: severe pain in your upper stomach spreading to your back, nausea, loss of appetite, dark urine, clay-colored stools, or jaundice (yellowing of the skin or eyes). If you've ever had hepatitis B, it may become active or get worse after you stop using lamivudine. You may need frequent liver function tests for several months. The hepatitis B virus may become resistant to treatment while you are taking Epivir-HBV . Resistant hepatitis B can lead to worsening liver disease or death. Tell your doctor if you have new hepatitis symptoms.
High Risk Groups
You should not take Epivir-HBV (for treating hepatitis B) if you also take other medicine that contains lamivudine or emtricitabine . Lamivudine can cause severe or life-threatening effects on your liver or pancreas. Call your doctor at once if you have: severe pain in your upper stomach spreading to your back, nausea, loss of appetite, dark urine, clay-colored stools, or jaundice (yellowing of the skin or eyes). If you've ever had hepatitis B, it may become active or get worse after you stop using lamivudine. You may need frequent liver function tests for several months. The hepatitis B virus may become resistant to treatment while you are taking Epivir-HBV . Resistant hepatitis B can lead to worsening liver disease or death. Tell your doctor if you have new hepatitis symptoms.
Adult Dosage
100 mg (100 (100)) 24 hourly PO — Scraped Dose — Follow all directions on your prescription label and read all medication guides or instruction sheets. Use the medicine exactly as directed. You should not take Epivir (for treating HIV) together with Epivir-HBV (for treating hepatitis B). You may take lamivudine with or without food. Lamivudine doses are based on weight in children. Your child's dose needs may change if the child gains or loses weight. Children who weigh more than 30 pounds (14 kilograms) should use the tablet form of lamivudine if possible. Lamivudine liquid may not be as effective. You may need to break an Epivir tablet in half when giving lamivudine to a child for HIV. Call your doctor if the child has any trouble swallowing the tablet. Measure liquid medicine carefully. Use the dosing syringe provided, or use a medicine dose-measuring device (not a kitchen spoon). The Epivir brand contains a higher dose of lamivudine than Epivir-HBV brand. Epivir is for treating HIV and Epivir-HBV is for treating hepatitis B. Each time you get a refill of this medication, be sure you have received the correct brand to treat your condition. You will need frequent medical tests, including frequent HIV testing. If you become infected with HIV while you are taking lamivudine to treat hepatitis B, the HIV could become resistant to antiviral medicines if not treated right away. The hepatitis B virus can mutate while you are taking Epivir-HBV and may become resistant to treatment. Resistant hepatitis B can lead to worsening liver disease or death. Tell your doctor if you have new or worsening hepatitis symptoms. Use all HIV medications as directed and read all medication guides you receive. Do not change your dose or dosing schedule without your doctor's advice. Every person with HIV should remain under the care of a doctor. Store at room temperature away from moisture and heat. Keep the bottle tightly closed when not in use. If you've ever had hepatitis B, this virus may become active or get worse in the months after you stop using lamivudine. You may need frequent liver function tests while using this medicine and for several months after your last dose.
Child Dosage
4 mg/kg (4 (4)) 12 hourly Oral —
Neonatal Dosage
( ) — Not recommended in this age group
Drug Interactions
Other drugs can affect lamivudine, and some drugs should not be used at the same time. Tell your doctor about all your current medicines and any medicine you start or stop using. This includes prescription and over-the-counter medicines, vitamins, and herbal products . Not all possible interactions are listed here.
Storage
Tab, Soln Store Below 40°C. Protect from Sunlight, Moisture and Heat.

Available Brands in Pakistan

27 active brands listed alphabetically.

AVONZA

Active

AGP (PRIVATE) LTD.

DML: AVONZA

Tabs

BELUM

Active

NAVEGAL LABORATORIES

DML: BELUM

Tabs

B-FIX

Active

EVERGREEN PHARMACEUTICALS PVT LIMITED

DML: B-FIX

Tabs

DULAM

Active

P.D.H. PHARMACEUTICALS (PVT) LTD.

DML: DULAM

Tabs

DUOVIR

Active

AJM Pharma Pvt Ltd DSL: 262

DML: DUOVIR

Tabs

HEPAID

Active

WELL & WELL PHARMA (PVT) LTD

DML: HEPAID

Tabs

LAMIDIN

Active

NOVA MED PHARMACEUTICALS

DML: LAMIDIN

Tabs

LAMIDINE

Active

PHARMATEC PAKISTAN (PVT) LTD.

DML: LAMIDINE

Tabs

LAMIKEU

Active

HIGH - Q INTERNATIONAL

DML: LAMIKEU

Tabs

LAMIRAL

Active

BOSCH PHARMACEUTICALS (PVT) LTD.

DML: LAMIRAL

Tabs

LAMIVA

Active

GETZ PHARMA PAKISTAN (PVT) LTD.

DML: LAMIVA

Tabs

LAMIVIR

Active

AJM Pharma Pvt Ltd DSL: 262

DML: LAMIVIR

TabsInj

LAMIVIR

Active

IRZA PHARMA (PVT) LTD.

DML: LAMIVIR

Oral Soln

LAMIWIN

Active

WNS FIELD PHARMACEUTICALS

DML: LAMIWIN

Tabs

LAMOZID

Active

NABIQASIM INDUSTRIES (PVT) LTD.

DML: LAMOZID

Tabs

LAMRIN

Active

PHARMEDIC (PVT) LTD.

DML: LAMRIN

Tabs

LAMUDINE

Active

ENGLISH PHARMACEUTICALS INDUSTRIES

DML: LAMUDINE

Tabs

LAMVIRA

Active

NABIQASIM INDUSTRIES (PVT) LTD.

DML: LAMVIRA

Tabs

LUMOVID

Active

GRAY`S PHARMACEUTICALS

DML: LUMOVID

Tabs

LYMBDA

Active

M SUUA PHARMA INTERNATIONAL

DML: LYMBDA

Tabs

MAXIVIR

Active

CCL Pharmaceuticals (Pvt.) Ltd. DML: 000052

DML: MAXIVIR

Tabs

RAFFAY

Active

SAFE PHARMACEUTICAL (PVT) LTD.

DML: RAFFAY

Tabs

VIROGEN

Active

GENE-TECH LABORATORIES

DML: VIROGEN

Tabs

VIROLEM

Active

STANDPHARM PAKISTAN (PVT) LTD.

DML: VIROLEM

Tabs

VUDIN-100MG

Active

GENOME PHARMACEUTICALS (PVT) LTD

DML: VUDIN-100MG

Tabs

ZEFFIX

Active

GLAXOSMITHKLINE

DML: ZEFFIX

Tabs

ZILAM

Active

MASS PHARMA (PRIVATE) LIMITED

DML: ZILAM

Tabs

5 additional records are present but flagged "Unverified / Legacy" and not listed.